PERITONITIS RATES IN CAPD PATIENTS USING THE UVXD AND O-SET SYSTEMS

被引：6

作者：

BAILIE, GR

RASMUSSEN, R

EISELE, G

LUSCOMBE, DK

机构：

[1] Department of Pharmacy Practice, Albany College of Pharmacy, Albany, NY

[2] Home Dialysis Unit, Albany Medical Center, Albany, NY

[3] Division of Nephrology, Albany Medical College, Albany, NY

[4] Division of Clinical Pharmacy, University of Wales College of Cardiff, Wales

来源：

RENAL FAILURE | 1993年 / 15卷 / 02期

关键词：

CAPD; Disconnect systems; O-set; Peritonitis; UVXD;

D O I：

10.3109/08860229309046156

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

We report experience with O-set and UVXD systems. Sixty-nine O-set patients (34 male; mean age +/- SD = 45.7 +/- 13.2 years) were compared with 54 UVXD patients (27 male; 56.8 +/- 16.8 years). Total (mean +/- SD) experiences were 974 (14.1 +/- 10.8) months on O-set and 1010.9 (18.7 +/- 15.7) months on UVXD. Thirty-two O-set patients avoided peritonitis; 3 7 had 91 episodes. Seventeen UVXD patients avoided peritonitis; 3 7 had 13 7 episodes. Peritonitis occurred each 10. 7 months (O-set) versus 7.4 months (UVXD), which was significantly different (p = 0.032, Z test; 95% confidence interval = -0.142 to + 0.226). There were 18 relapses in 9 O-set patients, 34 in 12 UVXD. Gram-positive organisms caused 58.2% and 66%; gram-negative, 13.2% and 8.8%; and culture negative, 24.2% and 23.4% of peritonitis in O-set and UVXD, respectively. The time to first peritonitis was not different, 7.4 +/- 6.6 months O-set and 7.2 +/- 7.9 months (UVXD). There was no difference in the peritonitis-free period, 13.0 +/- 10.0 months (O-set) and 16.5 +/- 14.3 months (UVXD). There were 1. 12 (O-set) and 16.1 (UVXD) cases per patient year, and 10.7 (O-set) and 7.43 (UVXD) patient months per episode. The peritonitis rate odds ratio was 1:1.85 (O-set:UVXD).

引用

页码：225 / 230

页数：6

共 27 条

[1]

Peterson P.K., Matzke G., Keane W.F., Current concepts in the management of peritonitis in patients undergoing CAPD, Rev Infect Dis, 9, pp. 604-612, (1987)

[2]

Saklayen M.G., CAPD peritonitis. Incidence, pathogens, diagnosis and management, Med Clin N Am, 74, pp. 997-1009, (1990)

[3]

Linblad A.S., Novak J.W., Nolph K.D., Stablein D.M., Cutler S.J., The 1987 USA National CAPD Registry report, Trans Am Soc Artif Intern Organs, 34, pp. 150-156, (1988)

[4]

Majorca R., Cancarini G.C., Brasa S., Et al., Y-system with disinfectant in the prevention of peritonitis in CAPD, Contrib Neph-rol, 57, pp. 178-184, (1987)

[5]

Viglino G., Colombo A., Scalamogna A., Et al., Prospective randomized study of two Y-devices in CAPD, Perit Dial Int, 9, pp. 165-168, (1989)

[6]

Buoncristiani U., The Y-set with disinfectant is here to stay, Perit Dial Int, 9, (1989)

[7]

Churchill D.N., Taylor D.W., Vas S.I., Et al., Peritonitis in CAPD: A multicentre randomized clinical trial comparing the Y connector disinfectant system to standard systems, Perit Dial Int, 9, pp. 159-163, (1989)

[8]

Maiorca R., Cancarini G.C., Colombrita D., Manili L., Camerini C., Further experiences with Y-system in continuous ambulatory peritoneal dialysis, Advances in CAPD., pp. 172-175, (1986)

[9]

Vonesh E.F., Modelling peritonitis rates and associated risk factors for individuals on continuous ambulatory peritoneal dialysis, Stat Med, 9, pp. 263-271, (1990)

[10]

Moncrief J.W., Rutherford C.E., Sorrels P.A.J., Bailey A., Popovich R.P., Technical aspects of CAPD new connection devices developed by Baxter Travenol Laboratories, Proceedings of the First International Symposium on CAPD., pp. 79-81, (1980)

← 1 2 3 →